YD Bio Limited (YDESW)
NGM
$0.28-0.01 (-3.45%)Quote refreshed
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Market Cap
—
P/E (TTM)
—
EPS
—
Div Yield
—
52W Range
$0.27–$0.31
Beta
-0.13
Company overview
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Peers in industry
YD Bio Limited has no peer companies in this window.
Recent press releases
YD Bio Limited has not issued a press release in this window.
SEC filings
All filings →YD Bio Limited has not filed an SEC document in this window.
Insider trades
All insider trades →YD Bio Limited has no reported insider trades in the last 90 days.
Institutional holders
All holders →As of 2025-12-31 · prior 2025-09-30
GEODE CAPITAL MANAGEMENT, LLC$711,444
58,363 sh+10.0%
27,540 sh-8.2%
Cerity Partners LLC$395,029
32,406 sh0.0%
MORGAN STANLEY$3,645
299 sh-97.1%
CITADEL ADVISORS LLC$140,782
11,549 sh● NEW
UBS Group AG$87,670
7,192 sh-30.3%
2,516 sh● NEW
CITIGROUP INC$20,833
1,709 sh● NEW
People at YD Bio Limited
All people →No officers or directors have been indexed for YD Bio Limited.
Quarterly financials
Full financials →No quarterly financials have been ingested for YD Bio Limited.